The reach of a hepatitis B vaccination programme among men who have sex with men

Baars, Jessica E.; Boon, Brigitte; Garretsen, H.F.L.; Mheen, Dike van de

doi:10.1093/eurpub/ckq117

Cited by 15 publications

(15 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Estimates that were based on serological proof ranged from 14% in a Danish study [33] to 30-38% in a Dutch study [34]. Another Dutch study, however, found a self-reported vaccination rate of 50% [35], which is similar to our results for the Netherlands (54.4%). In the Danish study participants also reported their vaccination rates, which were 18% higher than results from blood tests showed [33].…”

Section: Discussionsupporting

confidence: 84%

Are men who have sex with men in Europe protected from hepatitis B?

et al. 2020

View full text Add to dashboard Cite

Hepatitis B vaccination is recommended for men who have sex with men (MSM) in many countries, but information on vaccine coverage is scarce. We studied hepatitis B vaccination programmes and coverage among MSM in Europe to guide prevention. From a large (N = 174 209) pan-European MSM survey (EMIS-2010), we used data on self-reported hepatitis B vaccination, age, education, settlement size and disclosure of the same-sex sexual orientation (‘outness’). We excluded participants with a history of hepatitis B. In multilevel (participants, countries) logistic regression models, we calculated adjusted odds ratios (aOR) with 95% confidence intervals (95% CI). We analysed data of 163 987 MSM in 38 European countries: 38.3% were ‘out’ to all or almost all, 56.4% reported vaccination against hepatitis B and 65.5% lived in countries with free recommended hepatitis B vaccination for MSM. In the final model the odds for being vaccinated increased with outness (‘out to all or almost all’: aOR 1.76, 95% CI 1.70–1.83 vs. ‘out to no one’) and with living in countries, where hepatitis B vaccination was recommended and free-of-charge for MSM (aOR 2.21, 95% CI 1.47–3.32 vs. ‘no or unclear recommendation’). To increase hepatitis B vaccination coverage among MSM, implementation of MSM-specific recommendations and improvement of the societal climate for MSM is needed.

show abstract

Section: Discussionsupporting

confidence: 84%

Are men who have sex with men in Europe protected from hepatitis B?

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Concerns were analysed in more depth for specific vaccines. Articles looking at different vaccines without providing data on each vaccine separately [9][10][11][12][13][14][15][16] and vaccines for which there were only a handful of articles available [17][18][19][20][21][22][23][24][25][26] were excluded from the in depth analysis.…”

Section: Resultsmentioning

confidence: 99%

The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations

Karafillakis

Larson

2017

Vaccine

255

206

View full text Add to dashboard Cite

Findings: A total of 145 articles were selected, most of which were conducted in the UK, the Netherlands and France and studied seasonal influenza, HPV and pandemic influenza vaccination. Across all countries and vaccines, the primary area of concern was vaccine safety, followed by perceptions of low likelihood of contracting vaccine-preventable diseases (VPDs), perceived low severity of VPDs, beliefs that vaccines do not work, and overall lack of information. Concerns were found to be vaccine-, country-and populationspecific. Conclusion: In addition to identifying concerns about vaccination in Europe, this study confirmed the notion that individuals have many safety concerns about vaccination and often believe that the risks of vaccination outweigh their benefits. More research needs to be conducted to explore the impact of different types of communication strategies, which would frame the benefits of vaccination as well as risks of not vaccinating. Strategies to better inform public perceptions of vaccines should include the provision of unbiased, comprehensive information tailored to population information needs, and delivered using multiple and new communication technologies such as social media.

show abstract

“…Australian immunisation guidelines 88 continue to recommend HBV vaccination for all MSM, as do other international agencies. 89,90 However, 50% of MSM in some other countries have been vaccinated against HBV, 93,94 with testing for HBV and vaccination of nonimmune HIV-positive individuals occurring in only 52% and 25%, respectively. 95 Studies in immunocompetent adults continue to support the persistence of immune memory following HBV vaccination despite a fall in hepatitis B surface antibody (anti-HBs) titres, meaning further antibody testing and booster doses of HBV vaccine are unnecessary after completion of a vaccination course.…”

Section: Hepatitis B Virusmentioning

confidence: 99%

Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence

et al. 2014

View full text Add to dashboard Cite

Abstract.Men who have sex with men (MSM) in Australia and overseas are disproportionately affected by sexually transmissible infections (STIs), including HIV. Many STIs are asymptomatic, so regular testing and management of asymptomatic MSM remains an important component of effective control. We reviewed articles from January 2009-May 2013 to inform the 2014 update of the 2010 Australian testing guidelines for asymptomatic MSM. Key changes include: a recommendation for pharyngeal chlamydia (Chlamydia trachomatis) testing, use of nucleic acid amplification tests alone for gonorrhoea (Neisseria gonorrhoeae) testing (without gonococcal culture), more frequent (up to four times a year) gonorrhoea and chlamydia testing in sexually active HIV-positive MSM, time required since last void for chlamydia first-void urine collection specified at 20 min, urethral meatal swab as an alternative to first-void urine for urethral chlamydia testing, and the use of electronic reminders to increase STI and HIV retesting rates among MSM.

show abstract

The reach of a hepatitis B vaccination programme among men who have sex with men

Cited by 15 publications

References 10 publications

Are men who have sex with men in Europe protected from hepatitis B?

Are men who have sex with men in Europe protected from hepatitis B?

The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations

Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence

Contact Info

Product

Resources

About